Cargando...
Advances in immunotherapy for the treatment of glioblastoma
Glioblastoma (GBM) is an aggressive brain tumour, associated with extremely poor prognosis and although there have been therapeutic advances, treatment options remain limited. This review focuses on the use of immunotherapy, harnessing the power of the host’s immune system to reject cancer cells. Ke...
Gardado en:
| Publicado en: | J Neurooncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer US
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5258809/ https://ncbi.nlm.nih.gov/pubmed/27743144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-016-2299-2 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|